On the (almost) stochastic dominance of cryptocurrency factor portfolios and implications for cryptocurrency asset pricing
European Financial Management · 2024-06 · 30 (3) · 1125-1164
DOI: 10.1111/eufm.12431 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Financial Management, 2023-06. Verfasst von Weihao Han und 4 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cryptocurrency returns are highly nonnormal, casting doubt on the standard performance metrics. We apply almost stochastic dominance, which does not require any assumption about the return distribution or degree of risk aversion. From 29 long–short cryptocurrency factor portfolios, we find eight that dominate our four benchmarks. Their returns cannot be fully explained by the three‐factor coin model of Liu et al. So we develop a new three‐factor model where momentum is replaced by a mispricing factor based on size and risk‐adjusted momentum, which significantly improves pricing performance.
Zitieren
APA
Han, W., Newton, D., Platanakis, E., Sutcliffe, C., & Ye, X. (2024). On the (almost) stochastic dominance of cryptocurrency factor portfolios and implications for cryptocurrency asset pricing. European Financial Management, 30(3), 1125-1164. https://doi.org/10.1111/eufm.12431
Vancouver
Han W, Newton D, Platanakis E, Sutcliffe C, Ye X. On the (almost) stochastic dominance of cryptocurrency factor portfolios and implications for cryptocurrency asset pricing. European Financial Management. 2024;30(3):1125-1164. doi:10.1111/eufm.12431
BibTeX
@article{Han2024,
author = {Han, Weihao and Newton, David and Platanakis, Emmanouil and Sutcliffe, Charles and Ye, Xiaoxia},
title = {On the (almost) stochastic dominance of cryptocurrency factor portfolios and implications for cryptocurrency asset pricing},
journal = {European Financial Management},
year = {2024},
volume = {30},
number = {3},
pages = {1125--1164},
doi = {10.1111/eufm.12431}
}
EUVIMED